Dr. Becerra on Emerging Treatments in Pancreatic Cancer

Carlos Becerra, MD
Published: Thursday, Nov 16, 2017



Carlos Becerra, MD, physician, Texas Oncology, discusses emerging treatments for patients with pancreatic cancer.

Pancreatic cancer is one of the leading cancer-related deaths, states Beccera. There are currently no good treatment options, although progress has been made.

According to Beccera, newer chemotherapeutic agents and sequencing studies have helped to improve the field. Additionally, the new era of targeted therapy and immunotherapy will provide additional benefit that is needed for patients with metastatic pancreatic cancer.
 
SELECTED
LANGUAGE


Carlos Becerra, MD, physician, Texas Oncology, discusses emerging treatments for patients with pancreatic cancer.

Pancreatic cancer is one of the leading cancer-related deaths, states Beccera. There are currently no good treatment options, although progress has been made.

According to Beccera, newer chemotherapeutic agents and sequencing studies have helped to improve the field. Additionally, the new era of targeted therapy and immunotherapy will provide additional benefit that is needed for patients with metastatic pancreatic cancer.
 



View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Cancer Summaries and Commentaries™: Update from Atlanta: Advances in the Treatment of Chronic Lymphocytic LeukemiaFeb 28, 20190.5
Medical Crossfire®: Evolving Roles for Targeted Melanoma Therapies: Assessing Rapid Progress in the Field and Looking Toward Future CombinationsFeb 28, 20191.5
Publication Bottom Border
Border Publication
x